LXRX News
Lexicon Pharmaceuticals, Inc.
$1.86
+$0.04(+2.20%)
59
Overall
60
Value
72
Tech
47
Quality
Market Cap
$828.14M
Volume
3.41M
52W Range
$1.10 - $2.68
Target Price
$4.47
LXRX news: the latest Lexicon Pharmaceuticals, Inc. headlines, press releases and market updates, newest first.
Latest LXRX News
- Piper Sandler Remains a Buy on Lexicon Pharmaceuticals (LXRX)TipRanks Auto-Generated Intelligence Newsdesk · Nov 10, 2026
- Analysts Offer Insights on Healthcare Companies: Lexicon Pharmaceuticals (LXRX), Geron (GERN) and Medacta Group SA (OtherMEDGF)TipRanks Newsroom · Nov 9, 2026
- Analysts’ Top Healthcare Picks: Anixa Biosciences (ANIX), Lexicon Pharmaceuticals (LXRX)TipRanks Newsroom · Oct 27, 2026
- Analysts’ Opinions Are Mixed on These Healthcare Stocks: Lexicon Pharmaceuticals (LXRX), Amgen (AMGN) and Demant (OtherWILLF)TipRanks Newsroom · Oct 26, 2026
- Cantor Fitzgerald Reaffirms Their Buy Rating on Lexicon Pharmaceuticals (LXRX)TipRanks Auto-Generated Intelligence Newsdesk · Oct 20, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LXRX | $1.86 | +2.2% | 3.41M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Lexicon Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW